Xin Feng, Yuan Yongyi, Deng Xiaoming, Han Mingyu, Wang Guojian, Zhao Jiandong, Gao Xue, Liu Jun, Yu Fei, Han Dongyi, Dai Pu
Department of Otolaryngology and Genetic Testing Center for Deafness, Chinese PLA General Hospital, Beijing 100853, P,R, China.
J Transl Med. 2013 Dec 17;11:312. doi: 10.1186/1479-5876-11-312.
Each year in China, 30,000 babies are born with congenital hearing impairment. However, the molecular etiology of hearing impairment in the Yunnan Province population where more than 52 minorities live has not been thoroughly investigated. To provide appropriate genetic testing and counseling to these families, we investigated the molecular etiology of nonsyndromic deafness in this population.
Unrelated students with hearing loss (n = 235) who attended Kunming Huaxia secondary specialized school in Yunnan enrolled in this study. Three prominent deafness-related genes, GJB2, SLC26A4 and mtDNA 12S rRNA, were analyzed. High-resolution temporal bone computed tomography (CT) scan examinations were performed in 100 cases, including 16 cases with SLC26A4 gene variants, and 37 minorities and 47 Han cases without any SLC26A4 gene mutation.
The GJB2 mutation was detected in 16.67% (7/42) of minority patients and 17.62% (34/193) of Chinese Han patients (P > 0.05). 235delC was the hotspot mutation in nonsyndromic hearing loss (NSHL) patients, whereas 35delG was not found. The 431_450del19 mutation was detected for the first time in Han NSHL patients, which resulted in a premature stop codon and changed the protein. The SLC26A4 mutation was found in 9.52% (4/42) of minority patients and 9.84% (19/193) of Han Chinese patients (P > 0.05). The frequencies of mtDNA 12S rRNA mutation in minority and Han Chinese patients were 11.90% (5/42) and 7.77% (15/193; P > 0.05), respectively. Sixteen (16/23, 69.57%) patients with SLC26A4 mutations received temporal bone CT scan, and 14 patients were diagnosed with enlarged vestibular aqueducts (EVAs); the other 2 patients had normal inner ear development. The ratio of EVA in the minorities was 14.63% (6/41).
In this study, a total of 35.74% deaf patients showed evidence of genetic involvement, based on either genetic screening or family history; 17.45%, 9.79%, and 8.51% of the patients were determined to have inherited hearing impairment caused by GJB2, SLC26A4, and mtDNA 1555A > G mutations. There was no significant difference in deafness associated gene mutational spectrum and frequency between the Yunnan minority and Han patients.
在中国,每年有30000名婴儿出生时患有先天性听力障碍。然而,在居住着52个以上少数民族的云南省人群中,听力障碍的分子病因尚未得到深入研究。为了向这些家庭提供适当的基因检测和咨询服务,我们对该人群中非综合征性耳聋的分子病因进行了调查。
就读于云南昆明华夏中专学校的235名无血缘关系的听力损失学生参与了本研究。分析了三个主要的耳聋相关基因,即GJB2、SLC26A4和线粒体DNA 12S rRNA。对100例患者进行了高分辨率颞骨计算机断层扫描(CT)检查,其中包括16例携带SLC26A4基因变异的患者,以及37例少数民族患者和47例无任何SLC26A4基因突变的汉族患者。
少数民族患者中16.67%(7/42)检测到GJB2突变,汉族患者中17.62%(34/193)检测到GJB2突变(P>0.05)。235delC是本研究中非综合征性听力损失(NSHL)患者中的热点突变,未发现35delG突变。431_450del19突变首次在汉族NSHL患者中检测到,该突变导致了一个提前终止密码子并改变了蛋白质。少数民族患者中9.52%(4/42)检测到SLC26A4突变,汉族患者中9.84%(19/193)检测到SLC26A4突变(P>0.05)。少数民族和汉族患者中线粒体DNA 12S rRNA突变的频率分别为11.90%(5/42)和7.77%(15/193;P>0.05)。16例(16/23,69.57%)携带SLC26A4突变的患者接受了颞骨CT扫描,其中14例被诊断为前庭导水管扩大(EVA);另外2例内耳发育正常。少数民族中EVA的比例为14.63%(6/41)。
在本研究中,基于基因筛查或家族史,共有35.74%的耳聋患者显示出基因参与的证据;17.45%、9.79%和8.51%的患者被确定患有由GJB2、SLC26A4和线粒体DNA 1555A>G突变引起的遗传性听力障碍。云南少数民族和汉族患者之间耳聋相关基因突变谱和频率没有显著差异。